chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received flu shot 4 pm. At 7 pm for half hour had irresistible urge to cough. 7:30 felt throat swelling, developed metallic taste and joints ached. Called nurse thru poison control. She advised ER but patient just stayed home and took benadryl. Joint aching resolved in a couple hours. Metallic taste lasted into next day and sereation of swollen throat resolved next day.
I have a blood clot on the lower portion of my penis and Dr prescribed me a 7 day course of blood thinners
Right after the shot, I felt nauseas and lightheaded.  About 3 hours after the shot, I had body chills and my body was shaking uncontrollably for 3-4 hours. I am not sure how to describe this in a way that explains the magnitude of how the shaking felt but I've never had a similar experience and it was intense.  For the next 2 days, I felt weak and unable to eat normal foods (just easy foods like oatmeal). I also lost my sense of taste.  For the next month, I felt weak and unable to go for a run or exercise normally, needed a lot of sleep.
5days p/vax pt exp muscle soreness, fever & generalized, red blotches on temples, ears, back, & stomach. it was rpt pt devel at least 40 lesions.
Vaccine (Menomune) given SC 7/1/03. 7/2/03 began to notice swelling of arm which occurred 24 hours later. Tender and painful with flexion, slight erythema. Arm girth 10" left compared to 8" on right side. No temp. WBC 5.6. Follow up orthopedist - muscle inflammation.
Patient was administered the shot and shortly after started experiencing a shaking episode (not a seizure) and hot flashes.
he and his wife were around people tested positive, for covid; he and his wife were around people tested positive, for covid; This is a spontaneous report from a non-contactable consumer reported similar event for 02 patients. This is 1st of 02 reports.   This non-contactable Consumer reported that a 62-Year-old female patient (Wife) received bnt162b2 (BNT162B2), Batch/Lot number: unknown), dose1 via an unspecified route of administration on 12Mar2021 (at the age of 62-years-old), as 1st dose, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient and his wife were around people tested positive, for covid on unspecified date. The patient stated that His wife (age 62) received 1st dose of the  vaccine 12Mar2021, scheduled 02Apr2021 for second dose, he and his wife were around people tested positive, for covid. Caller states: He received both doses of the Pfizer covid vaccine last month, in February, and his wife is due to get the second dose in April. he enquired if she could go and get the vaccine? Response: Spoke from attached documents CONS - post-vaccination precautions - wearing a mask and social distancing after receiving the vaccine (v5.0). the patient was asked to still take steps to protect himself and others in many situations, like wearing a mask, staying at least 6 feet apart from others, and avoiding crowds and poorly ventilated spaces. Take these precautions whenever they are: In public, gathering with unvaccinated people from more than one other household, visiting with an unvaccinated person who was at increased risk of severe illness or death from COVID-19 or who lives with a person at increased risk. We're still learning how long COVID-19 vaccines can protect people. As we know more, CDC will continue to update our recommendations for both vaccinated and unvaccinated people. CONS-Can they Receive the Vaccine with a Prior or Current COVID-19 Diagnosis (US) (v2.0): These interim considerations also state that if you currently have a COVID-19 (either before the first dose of vaccine or in between your first and second dose of vaccine), you should wait until you have recovered from the infection, show no symptoms, and completed any required isolation. Please be sure to discuss any questions about receiving the vaccine and if you have COVID-19 or develop COVID-19 after receiving the first dose with your vaccination provider, doctor, or other health care professional. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021314110 same reporter/product/events, different patient.
left size of face went numb but regained feeling within 3 hours; weakness in left arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 (Lot number: ER8733) at the age of 27 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HYPOAESTHESIA (non-serious) with onset 31Mar2021, outcome "unknown", described as "left size of face went numb but regained feeling within 3 hours"; MUSCULAR WEAKNESS (non-serious) with onset 31Mar2021, outcome "unknown", described as "weakness in left arm". Therapeutic measures were not taken as a result of hypoaesthesia, muscular weakness.  Additional Information: After first dose within 1 hour left size of face went numb but regained feeling within 3 hours. Experienced weakness in left arm up to 4 days later. No vaccine in four weeks. Medications in two weeks was none. No covid prior vaccination. No covid tested post vaccination. No Known allergies.  No follow-up attempts are possible. No further information is expected.
Swollen throat, passed out, no fever, nausea cold sweat chills sore area x 3 days.
Missed AB diagnosed 4/7/21 via ultrasound. Pregnancy initially confirmed via serum HCG 2/24/21. Ultrasound Confirmed and dated at 6w5d with heartbeat on 3/10/21 with an EDD of 10/29/21.  Covid  Vaccine administered 3/17/21.  Next appointment 4/7/21 no visible heartbeat w/ ultrasound.  Suction D&C performed 4/9/21. Sent for pathology and chromosomal testing, results pending as of 4/15/21.
On 15 Feb, he went out to the field and around 10 AM he developed itching in his legs. The itching spread to his chest and by 6 PM when he returned from the field and took off his clothes he noticed he was covered from head to toe (including scalp, soles of feet) with a red, swollen, itchy rash. There were large areas as well as smaller patches. He denies any other symptoms. He was seen in the ER and given PREDNISONE 40 mg and BENADRYL 50 mg. He was seen the 2 days later and referred by Allergy for further evaluation. He discontinued the steroid and antihistamine as directed in case allergy testing was going to be done. His diagnosis in the ER was urticaria and the rash/itching responded to steroids and antihistamines. He denies any other sxs such as myalgias, fever or swelling of the extremities. The rash resolved 2 days after it started but the itching has continued. He currently has itching that comes and goes in different places and he is only sleeping 2-3 hours at night due to the discomfort. He was previously healthy and has never had hives before. He used fabric protector on his boots 2 days before the rash and wore a new uniform on the day of the rash. No new detergent. He denies being on any medications. No new foods. While out in the field, he was performing road duty in the cold. No new exposures. He received the ANTHRAX #2 vaccine 9 Feb. Small pox vaccine #2 on 26 Jan (repeat after first didn't take 19 Jan). ANTHRAX #1 Jan 19th. Symptoms: Hives, pruritis.
Moderna COVID-19 Vaccine EUA No fever, but very incoherent for several days, sleeping 12-14 hours overnight, then snoozing in chair for most of the day; eyes were extremely sore, burning, stomach distressed, a bit of diarrhea, arm was stiff,  red and sore at point of injection, all over joint stiffness and achiness.  These symptoms slowly improved, but lasted at least 5 days.  Redness and itchiness at point of injection returned on Saturday, 3/6, still red and itchy today 3/8.  Eyes also burning again.
Headaches for 2 weeks tired for 2 weeks sinus congestion for 2 weeks left side of throat sore month.
Rheumatoid Arthritis systems started with a peak in symptoms in April. Confirmed diagnosis in November. No symptoms prior to vaccination.
shortly after vaccine admin, patient states felt weakness all over, feeling like needing to lie down, light sensitivity, "gel legs". arrived to obs 1122, bp 155/83, hr 54, rr 18, sao2 97% on ra.  continued to c/o lightheadedness lying, sitting and standing, ortho bp/hr 167/82 52 lying, 163/76 54 sitting, 154/82 54 standing. states has low hr, n propanolol. 1230p ems called due to unrelieved dizziness/lightheadedness for transport to hospital, report provided to ems.
Redness-- > Monday doubled in size, fever, no heat,  hardness, chills on Monday and Tuesday; Tuesday doubled again, MD Tuesday afternoon started Keflex h/x of MRSA
Fever, cough, shortness of breath, difficulty breathing, Chest pain, fatigue. Death: 8/14/2021
Information has been received from a NP concerning a 26 year old female who on 09/10/03 was vaccinated with a dose of varicella virus vaccine live (Lot # 644090/1065M). The NP reported that on approximately 09/23/03, the pt developed a mild case of chickenpox characterized by approximately 16 or 17 lesions diffusely scattered on her trunk, head and limbs. The pt was also noted to have mild lymphadenopathy, fever and malaise. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
paresthesia of left shin and foot/paresthesia has continued intermittently to bilateral arms and shins to this date; dizziness; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 23Nov2021 14:45 (Lot number: 330308D) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergies: Sulfa" (unspecified if ongoing); "Covid" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: Multivitamins, ZINC; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]. Past drug history included: Zithromax for product used for unknown indication, reaction(s): "Known allergies: Zithromax". The following information was reported: PARAESTHESIA (non-serious) with onset 26Nov2021, outcome "not recovered", described as "paresthesia of left shin and foot/paresthesia has continued intermittently to bilateral arms and shins to this date"; DIZZINESS (non-serious) with onset 26Nov2021, outcome "unknown", described as "dizziness". Therapeutic measures were not taken as a result of paraesthesia, dizziness.  No follow-up attempts are possible. No further information is expected.
expired Menactra was given to a patient/an expired 0.5ml dose of Adacel was administered in MT's right deltoid with no ae; Initial information received on 30-Mar-2021 regarding an unsolicited valid  non-serious case from a other health professional (reference number :00540911).  This case involves a 16 years old female patient who received expired 0.5 ml doses of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (lot number and expiration date not reported via unknown route in the right deltoid) and MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot U6565AA and expiration date:28-Mar-2021 via unknown route in an unknown administration site) for prophylactic vaccination on 29-Mar-2021 (expired product administered). And reporter wanted to know what to do.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MEDROXYPROGESTERONE ACETATE (DEPO PROVERA, injection) on that same visit (that is on 29-Mar-2021).  It was an actual medication error due to expired vaccine used (same day latency).  It was not reported that the patient experienced any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number of Adacel for this case.
Seeing colors brilliantly.I wonder if it has somehow repaired my cones/rods. Also wondering if it has helped my blood pressure; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that an unspecified age and gender patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number Unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical and concomitant medications were not reported. On an unspecified date, patient was seeing colors brilliantly. Patient knew that it was not something Pfizer has concerned with but was wondering if it has somehow repaired patient's cones/rods. Also wondering if it has helped blood pressure, of it was having started using progesterone. Prior to this, patient had very negative side effects from cardiac meds, so started progesterone and it seems to be helping. But was wondering if the shot was somehow fixing things. The outcome of the event was unknown.  Information about lot/batch number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 70-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Jul2023 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Slight kidney decrease in function" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 22Sep2023 till 27Sep2023.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-202300317295 same reporter/patient, different drug/AE;
RN responded to pt's report of centralized face numbness (reaching out to eyebrows, mid-cheek, upper chin). Denied other symptoms. VS: BP 130/80, SpO2 98%, HR 55, RR 18. RN stayed with pt for 10 minutes, pt reported numbness stayed the same, no new symptoms reported. VS rechecked at 15 min:  BP 130/90, HR 55, RR 16, SpO2 99%. Arm strength 5/5 bilaterally. RN called EMS due to facial numbness; gave report when EMS arrived. EMS assessed pt, released him to home with instructions to call 911 if any further symptoms. Pt said that he was returning home and he would have a family member there.
The day of receiving vax the pt developed an injection site reaction characterized by tenderness, swelling, redness and warmth. She was treated with Benadryl and applications of moist heat. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune-23 lot 466-440.
Patient brought in by mother acutely for complaints of having low-grade fever, body aches and chills.  Also nauseated. He feels sleepy and has slightly stiff neck. Patient was seen yesterday for his 16-year-old wellness exam. He was given MENACTRA, FLUZONE and TRUMENBA. He has no sore throat. No cough symptoms. Negative for runny nose. He has no confusion. He has no diarrhea or urinary symptoms. Negative for rash. His main complaint is that of chills, feels like his body is burning up and body ache. It is flulike symptoms. He has had no foreign travel or unusual exposure. He was not sick yesterday. He is an otherwise healthy individual who is progressing and meeting all milestones. He is academically strong and has been healthy through time. No prior reaction to any immunizations in the past. He did do well with flu shots in the past as well as MENACTRA.
This is a spontaneous report based on the information received by Pfizer from Merck Inc, service requested number: 1-8394727844. A non-contactable pharmacist reported that a physician told her about a female patient of unknown age and ethnicity that developed a rash on her body after receiving PREVNAR 13, single dose. No follow up attempts possible. No further information expected.
After shot within the week I started my period, but it was unusually heavy. Pimples that I picked kept bleeding. 1/27 got up around 6:30am took shower and noticed large bruised on leg and lower back and hip and various places. Also noticed little petechiae. I called the doctor. 1/28 went and did blood test-platelets in blood decrease excessively. I went to the hospital ER 1/29. Did CT scan- no bleeding. Did a platelet transfusion and still continued to drop. I was admitted about 9pm and saw doctor next morning. I was hospitalized for 4 days and was prescribed dexamethasone for two days then prednisone.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a parent concerned a 27 year old white female. The patient's height, and weight were not reported. The patient had no known allergies and was not on any medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, and expiry: Unknown) dose was not reported, 1 total, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 12-MAR-2021, 10 hours after vaccination the patient experienced fever, headache, and nausea which lasted about 8 hours. On 06-AUG-2021, the patient started experiencing symptoms of COVID-19 (stuffed nose, fever, suspected clinical vaccination failure and suspected covid-19 infection). On 08-AUG-2021, the patient went to doctor care (urgent care center) where she had nasal swab rapid test. Laboratory data: COVID-19 antigen test (NR: not provided) positive. The reporter stated that the patient had not notified her Health Care Professional (HCP) that she had tested positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and fever, headache, and nausea on 13-MAR-2021, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000192839. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. This case, from the same reporter is linked to 20210851625.; Sender's Comments: V0: 20210918762-Covid-19 vaccine ad26.cov2.s-Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
On 10/23/14, patient reported that she had dizziness and nausea after she received the vaccine.  The patient took tylenol and Benadryl right away.  Later that evening she developed stomach cramping, nausea, vomiting, diarrhea, patient had to take prednisone 10 mg x1 and was relieved within 30 minutes.
I had my vaccination on 09/21/2022. I started to have a scratchy throat on 05/16/2023. I tested COVID-19 Positive on 05/18/2023. I was not provided a course of treatment. I was told to treat for aches and pains and fever. I am presently still experiencing congestion and coughing on 05/24/2023. These symptoms are becoming less and less each day.
Tingling in my hands. Feels like carpel tunnel and fingers feel hot inside .Adrenaline throughout my body that i can cant sleep.
This is a spontaneous report from a Pfizer-sponsored program. A contactable healthcare professional reported that a 67-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (trade name and manufacturer were not reported), with route of administration and therapy dates unspecified, at a single dose for immunization; bacitracin (trade name and manufacturer were not reported), with route of administration, therapy dates, dose, frequency and indication unspecified; ibuprofen (trade name and manufacturer were not reported), with route of administration, therapy dates, dose, frequency and indication unspecified; NEOSPORIN, with route of administration, therapy dates, dose, frequency and indication unspecified; ASPIRIN, with route of administration, therapy dates, dose, frequency and indication unspecified; BENADRYL, with route of administration, therapy dates, dose, frequency and indication unspecified; SENOKOT, with route of administration, therapy dates, dose, frequency and indication unspecified; SUDAFED NON-DRYING SINUS, with route of administration, therapy dates, dose, frequency and indication unspecified; and VERSED, with route of administration, therapy dates, dose, frequency and indication unspecified. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had drug allergies with pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein), bacitracin, ibuprofen, gramicidin, neomycin sulfate, polymyxin b sulfate, acetylsalicylic acid, diphenhydramine hydrochloride, sennoside a+b, guaifenesin, pseudoephedrine hydrochloride, midazolam hydrochloride and cephalosporins (unspecified). The action taken in response to the event was not applicable for pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein); and was unknown for bacitracin, ibuprofen, gramicidin, neomycin sulfate, polymyxin b sulfate, acetylsalicylic acid, diphenhydramine hydrochloride, sennoside a+b, guaifenesin, pseudoephedrine hydrochloride and midazolam hydrochloride. The outcome of the event was unknown. Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein), bacitracin and ibuprofen in the reporter's country. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein), bacitracin and ibuprofen has submitted the same report to the regulatory authorities.
pt states he started feeling ill a couple of hours after getting the vaccine and developed a body rash from head to toe.  It was like long red whelps.  He is taking allergy relief medication and has taken this for almost 2 months.    His rash still comes and goes now but not as severe.